Miscellaneous
Pierre Pellier is CEO of CTMA and is driven to provide better access to innovative and potentially life-saving therapies to more patients. The key is to shorten the duration of clinical trials by more quickly and efficiently identifying and recruiting potentially eligible participants. Using the CT-Scout platform on a mobile device, doctors are prompted to ask, during a consultation, a few selected questions to determine whether a particular patient might be eligible for any of the numerous studies running at their site. Removing the need to remember major inclusion and exclusion criteria encourages doctors and investigators to broaden the search and increase recruitment. @CScoutTm #CTMA #clinicaltrials #patientrecruitment CTMA.fr Download the transcript here